CS Paper Radar

Towards clinical adoption of voice and speech as measures of health: the need for harmonization

Nicholas Cummins, Vikram Ramanarayanan, Daniel Low, Fabio Catania, Si-Ioi Ng, Caterina Botelho, Judith Dineley, Abir Elbeji, Julie M. Liss, Paula Andrea Perez-Toro, Visar Berisha, Thomas Quatieri

cs.ET cs.SD ·submitted 2026-09-24 01:14 UTC · v1

Abstract

Speech and voice are multidimensional signals that capture both communicative intent and underlying physiological processes, providing a unique, non-invasive window into health. Analyzing these signals has the potential to yield digital biomarkers that (i) provide scalable, objective measurement tools for research and clinical care and (ii) reflect the presence or progression of diverse conditions, including neurological, psychiatric, respiratory, and cardiovascular disorders. Realizing this promise, however, requires the field to overcome pervasive reproducibility and generalizability issues due to heterogeneous data collection, processing, and analysis practices. A major source of this heterogeneity is how underlying acoustic measures themselves are defined and computed. In this paper, we outline key considerations across the speech biomarker discovery lifecycle, from data collection through machine learning modeling to clinical interpretation, needed to achieve reliable, reproducible, and clinically translatable results. Chief among these is the need for harmonization efforts to start from common, precisely specified measure definitions. As a first step, we therefore provide definitions, physiological correlates, and computational implementations for a minimal, clinically interpretable set of core speech measures spanning respiration, phonation, articulation, and fluency. We close by discussing ongoing standardization efforts and the open challenges that remain in advancing the adoption of speech- and voice-based digital biomarkers.

Closest papers

Nearest neighbours by meaning across the whole index.

SpiroPhonia: Non-Invasive Respiratory Health Assessment from Spontaneous Speech

cs.SD ·2026-09-15 ·Roksana Khanom, Shafia Supty, Nirupam Roy, Ashok Agrawala
top venuedatasethot direction similarity 0.74
Abstract · Accepted at Interspeech 2026, Sydney, Australia

Chronic Obstructive Pulmonary Disease (COPD) remains a major global health challenge, emphasizing the need for accessible and non-invasive detection. Since speech production is fundamentally linked to respiratory physiology, its disruptions can serve as indirect indicators of pulmonary impairment. This study introduces SpiroPhonia, a machine learning framework that leverages spontaneous speech for respiratory health assessment. We evaluated SpiroPhonia on a new dataset of 201 speakers (102 with COPD, 99 healthy controls). By integrating statistical analysis with recursive feature selection, we identified a compact set of discriminative speech markers. Our best model achieved 78% accuracy, 80% F1-score, and 87% AUC. This performance on spontaneous speech is competitive with methods using controlled laboratory recordings. Findings demonstrate that everyday speech encodes robust respiratory biomarkers, paving the way for continuous health monitoring via voice-enabled technologies.

0.65

Acoustic Biomarkers for Alzheimer's Disease Detection from Spontaneous Speech

eess.AS cs.LGcs.SD ·2026-09-30 ·Anh L Tran, Arjee Javellana Restar, Bereket Kindo
similarity 0.72
Abstract

Alzheimer's disease (AD) remains a major public health challenge, and early identification is crucial for timely intervention and care planning. Recent work has shown that speech-based digital biomarkers can capture subtle changes in vocal production, prosody, and timing that often precede or accompany cognitive decline. In this study, we investigate whether acoustic features extracted from spontaneous speech can reliably distinguish individuals with AD from healthy controls. Using a structured speech dataset derived from the Cookie Theft picture-description task, we extract clinically informative low-level descriptors spanning prosodic, spectral, and temporal domains, and evaluate a range of machine learning classifiers. Our results indicate that acoustic biomarkers carry strong discriminative value, with the best-performing models achieving clinically meaningful separation between diagnostic groups. These findings support the use of non-invasive, low-cost audio-based screening tools and motivate further work on multimodal and longitudinal assessment frameworks for dementia risk detection.

0.29

Listening for Airway Stenosis: A Foundation Model-Based Method for Rapid and Accessible Detection

cs.SD ·2026-09-14 ·Jean Groeninger, Zihao Zhao, Juliana de Castilhos, Sven Nebelung, Daniel Truhn
code/data similarity 0.67
Abstract · Jean Groeninger and Zihao Zhao contributed equally. Code is available at https://github.com/JeanGrng/listening-for-airway-stenosis

Airway stenosis can cause severe respiratory complications, yet its detection often relies on specialized examinations and medical imaging. This study explores the potential of acoustic AI for rapid and accessible airway stenosis detection using readily acquired patient voice recordings. We systematically investigate whether acoustic foundation models (AFMs) can extract acoustic representations associated with airway stenosis-related speech patterns. Experiments are conducted on a cohort of 748 participants from the Bridge2AI-Voice dataset, 134 with airway stenosis and 614 without. The best-performing model achieves an AUROC of 0.952 and an accuracy of 0.924 (means over five-fold cross-validation), highlighting the potential of AFMs to transfer beyond general-purpose speech applications to clinical diagnostic tasks. Further analysis reveals that the model primarily relies on connected-speech recordings rather than isolated acoustic tasks, such as sustained phonation and breathing. Overall, these results suggest that voice-based acoustic AI could complement existing diagnostic workflows by enabling rapid, low-burden, and widely accessible screening for airway stenosis.

0.43

BioSync: Transformer-Based Cross-Modal Fusion for a Multimodal Physiological Digital Biomarker

cs.AI cs.IR ·2026-09-03 ·Seyed Mahmoud Sajjadi Mohammadabadi
benchmark similarity 0.66
Abstract

Cardiac, neural, behavioral, and speech measurements from wearable and mobile devices provide partial, noise-sensitive views of physiological state. BioSync combines these measurements into the \textbf{BioSync Index (BSI)}, a continuous composite digital biomarker defined under the BEST framework. The model applies multi-head self-attention to modality tokens and adds a linear branch whose hypothesis class includes standard feature concatenation. This architecture is motivated by latent-variable measurement theory and by the possibility that joint observations contain information unavailable from individual modalities. We evaluated BioSync on two literature-informed synthetic cohorts: a four-modality cognitive-decline cohort using HRV, EEG, actigraphy, and speech, and a metabolic-autonomic cohort structured around the public AI-READI wearable schema. In the cognitive cohort, BioSync and concatenation obtained AUCs of 0.928 and 0.926, respectively. In the metabolic cohort, BioSync obtained accuracy/F1 of 0.764/0.766, compared with 0.756/0.758 for concatenation. The BSI correlated with latent severity in both cohorts ($r=0.91$ and $r=0.68$). A pure-attention ablation obtained cognitive-cohort AUC 0.911, locating the increase to 0.928 in the combined wide-and-deep architecture. With matched modality-dropout training, BioSync led concatenation at five of six cognitive-cohort corruption rates and at the highest metabolic-cohort rate. Its cognitive-cohort AUC was also higher than five published digital-biomarker reference values, although differences in datasets and tasks preclude a controlled benchmark claim. Comparison with single-modality, early-fusion, and late-fusion designs across six prespecified criteria identifies the model's computational properties; validation on real cohorts remains necessary.

0.17

BreathGRU: A Novel Semi-Supervised Bidirectional Gated Recurrent Unit Framework for Speech and Breath Segmentation for Respiratory Audio

cs.SD cs.LGeess.AS ·2026-09-25 ·Sania Fatima Sayed, John W. Holloway, Reyer Zwiggelaar, Faisal I. Rezwan
similarity 0.64
Abstract

Speech-breath segmentation is a fundamental preprocessing step in respiratory audio analysis, enabling applications such as respiratory acoustic biomarker extraction, lung function prediction and disease monitoring. Existing approaches, including threshold methods, Fourier Transform-based techniques, and unsupervised and pretrained voice activity detection (VAD) models, primarily focus on speech detection and often classify breathing events as non-speech or silence, limiting their applicability for precise breath detection. To address this limitation, we propose BreathGRU, a semi-supervised Bidirectional Gated Recurrent Unit (BiGRU) framework specifically designed for speech-breath segmentation. The proposed framework combines frame-level acoustic feature extraction with bidirectional recurrent modelling, pseudo-label refinement and duration-constrained Segmental Viterbi decoding to produce speech and breath segmentation. BreathGRU was evaluated against the existing approaches, using manually annotated recordings. Performance was assessed using event-based, time-based, overlap-based, duration-based and boundary-based segmentation metrics. Experiment results demonstrated that BreathGRU achieved the highest breath event recall (0.83), the lowest onset-localisation error (0.14s) and the highest Mean Match Intersection over Union (0.81), with competitive overall segmentation performance compared to large pretrained VAD models like Silero. Qualitative evaluation on manually annotated recordings further showed close agreement between BreathGRU and manual annotation, with better breath detection compared to Silero. These findings demonstrate that explicit breath event modelling provides advantages over general-purpose VAD models and establish BreathGRU as an effective speech-breath segmentation framework which can be applied for respiratory audio analysis and pulmonary healthcare applications.

0.29

An Initial Study of Physiological Markers for Deepfake Speech Detection

cs.SD cs.CRcs.CVcs.LG ·2026-10-13 ·Vojtěch Staněk, Michal Frič, Kamil Malinka, Anton Firc
published similarity 0.64
Abstract · Accepted at BIOSIG 2026

Conventional deepfake speech detectors primarily target synthesis artifacts and often degrade under unseen attacks or recording conditions. Human speech, however, contains physiological markers associated with respiration, phonation, and temporal coordination arising from the speech-production system that synthesizers may not reproduce faithfully. This motivates the hypothesis that deepfake speech can be detected by identifying inconsistencies in these patterns, which we test using 36 handcrafted physiological markers organized into respiratory, vocal, and temporal categories. We evaluate the marker vectors with logistic regression and SVM classifiers on pooled English recordings. The best in-domain system achieves a 21.40% equal error rate (EER), while logistic regression achieves 32.77% on the out-of-domain dataset pair. Since the markers describe specific speech-production properties, the logistic-regression coefficients indicate whether higher marker values push the classifier toward bona fide or deepfake speech. These results provide initial evidence that physiological markers offer a useful, interpretable signal for deepfake speech detection.

0.35

Automatic estimation of verbal fluency index in people with Motor Neuron Disease using ASR alignment and pause modelling

cs.CL cs.AIeess.AS ·2026-09-22 ·Bahman Mirheidari, Leslie Ing, Daniel Blackburn, Sharon Abrahams, Christopher McDermott +1 more
similarity 0.64
Abstract

Monitoring cognitive impairment (CI) in motor neuron disease (MND) is essential for timely treatment and care, yet challenging due to co-occurring speech difficulties. The Edinburgh Cognitive and Behavioural ALS Screen (ECAS) provides a robust metric for CI assessment, with the Verbal Fluency Index (VFI) a central element. Building on recent advances in automated speech analysis, this study proposes a system for estimating VFI. It leverages a unique MND dataset and combines ASR (WhisperX) and VAD (Silero) with refined timestamping to predict the VFI and extract several clinically interpretable measures. Our approach outperformed systems based on traditional acoustic features and self-supervised embeddings, evaluated using multiple regression algorithms. Clinically inspired features consistently outperformed the other sets, with the best models achieving strong results (P-words: R2 0.9, NRMSE 0.05; S-words: R2 0.8, NRMSE 0.08), demonstrating the feasibility of automated VFI estimation.

0.25

A Cross-Lingual Acoustic Disease-Alignment Framework for Respiratory Health Assessment from Spontaneous Speech

cs.SD cs.CL ·2026-09-16 ·Roksana Khanom, Raghib Asfak Tasnim, Bodrun Nahar Bithi, Shafia Shirin Supty, Saiful Islam Raju +2 more
similarity 0.63
Abstract · Under review

Spontaneous speech offers a scalable, noninvasive signal for respiratory health assessment, yet interpretable models that generalize across languages remain challenging because disease-related acoustic changes are confounded by language-specific phonetic variation. We present CL-DAF, a Cross-Lingual Disease-Alignment Framework that identifies acoustic dimensions whose disease effects remain consistent across languages. Using 201 English and 75 newly collected Bangla speakers, we construct a common 272-dimensional acoustic representation and quantify disease alignment using signed rank-biserial effects and the Language Invariance Score. We first show that spontaneous Bangla speech separates COPD from controls (AUC 0.85); however, 133 features reverse their disease direction across languages and the full representation transfers poorly (AUC 0.49 from Bangla to English). CL-DAF isolates 26 disease-aligned features that raise AUCs to 0.825 and 0.722 from English to Bangla and Bangla to English, respectively. These findings provide a foundation for multilingual clinical speech models emphasizing pathology over language-dependent variation.

0.31